Sharing my ground breaking work on what to do when #Alzheimer's biomakers do not agree.
@aanmember.bsky.social @capsutaustin.bsky.social @texas-aging.bsky.social @texasneuros.bsky.social @uttyler.bsky.social @qmuldementia.bsky.social
Blood-based biomarkers are increasingly used to triage patients for amyloid confirmation, yet performance is often reported versus a single comparator despite discordance between amyloid PET and CSF. ...
